Positron Emission Tomography in Limited-Stage Small-Cell Lung Cancer: A Prospective Study

Positron emission tomography provides molecular imaging of biological processes

2000 • 1,176 citations

[Cancer of the lung].

1954 • 861 citations

AJCC Cancer Staging Manual, 6th edition

2003 • 540 citations

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

1990 • 385 citations

18F-Deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis

1999 • 354 citations

Alkylating agents in bronchogenic carcinoma

1969 • 353 citations

PET imaging in oncology

2000 • 342 citations

The impact of 18 FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study

2002 • 313 citations

The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer

2000 • 286 citations

Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods

2000 • 250 citations

Carbon-11-thymidine and FDG to measure therapy response.

1998 • 215 citations

An overview of prognostic factors in small cell lung cancer

1990 • 206 citations

FDG–PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology

2002 • 203 citations

The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Presented at the 13th Asia Pacific Cancer Conference, Penang, Malaysia, November 17–20, 1996 and also presented at the Royal Australasian College of Radiologists 47th Annual General and Scientific Meeting, Perth, Western Australia, October 5–9th, 1996. Accepted for presentation at the American Radium Society 79th Annual Meeting, New York, N.Y., April 30–May 4, 1997.1

1998 • 189 citations

Prognostic value of [ 18 F]FDG-PET imaging in small cell lung cancer

2003 • 171 citations

Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects

1999 • 170 citations

Quantitative assessment of tumor metabolism using FDG-PET imaging

2000 • 159 citations

Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.

2003 • 155 citations

CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers

2001 • 145 citations

FDG-PET imaging for the staging and follow-up of small cell lung cancer

2001 • 129 citations

Staging, prognostic factors, and special considerations in small cell lung cancer.

1988 • 90 citations

Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study

2002 • 76 citations

Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer.

2002 • 65 citations

Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomography.

1998 • 17 citations